Supernus Pharmaceuticals (SUPN) Cost of Revenue (2013 - 2026)
Supernus Pharmaceuticals (SUPN) reported Cost of Revenue of $33.67 million for Q2 2026, up 100.1% from $16.83 million a year earlier.
Powered by 
Analysis
Supernus Pharmaceuticals (SUPN) Cost of Revenue (2013 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Supernus Pharmaceuticals' Cost of Revenue came in at $92.47 million, up 21.2% year-over-year; for FY2025, it was $74.56 million, down 4.3% from FY2024.
- Cost of Revenue has declined for three consecutive years, though with a five-year compound annual growth rate of 7.3% (FY2020 to FY2025).
- By year, Cost of Revenue came in at $77.91 million in FY2024 (-7.0%), $83.78 million in FY2023 (-3.9%), $87.22 million in FY2022 (+16.2%) and $75.06 million in FY2021 (+43.1%).
- The Q2 2026 figure ranks as the highest quarterly Cost of Revenue in data going back to Q2 2013.
- Year over year, Cost of Revenue gained in three of the last seven quarters, with growth averaging 15.6%.
- The high point for year-over-year Cost of Revenue in five years was Q2 2026 (growth of 100.1%); the low point was Q1 2024 (a decline of 30.5%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.27 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 8.05 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 4.29 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 4.40 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 3.71 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.52 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 2.81 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.58 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.09 Bn |
| 10 | Supernus Pharmaceuticals | 2.47 Bn | 1.12 Bn | 185.39 Mn | 33.67 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 33.67 Mn |
| Dec 31, 2025 | 23.01 Mn |
| Sep 30, 2025 | 18.97 Mn |
| Jun 30, 2025 | 16.83 Mn |
| Mar 31, 2025 | 15.76 Mn |
| Dec 31, 2024 | 26.10 Mn |
| Sep 30, 2024 | 17.58 Mn |
| Jun 30, 2024 | 17.92 Mn |
| Mar 31, 2024 | 16.31 Mn |
| Dec 31, 2023 | 19.63 Mn |
| Sep 30, 2023 | 19.60 Mn |
| Jun 30, 2023 | 21.09 Mn |
| Mar 31, 2023 | 23.46 Mn |
| Dec 31, 2022 | 22.95 Mn |
| Sep 30, 2022 | 25.88 Mn |
| Jun 30, 2022 | 20.46 Mn |
| Mar 31, 2022 | 17.93 Mn |
| Dec 31, 2021 | 16.99 Mn |
| Sep 30, 2021 | 18.09 Mn |
| Jun 30, 2021 | 25.03 Mn |
API Access
Supernus Pharmaceuticals Cost of Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=SUPN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cost-of-revenue", "ticker": "SUPN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=SUPN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();